AZN and Daiichi Near Price Agreement with NICE for Enhertu

AZN and Daiichi are close to reaching a price agreement with NICE for the drug Enhertu. The outcomes of the ongoing negotiations between the parties have not yet been disclosed. The agreement is expected to be a significant step in drug pricing. The collaboration aims to optimize drug access and cost management through the joint efforts of the two companies. Details of the agreement will proceed under the confidentiality agreements of the parties. Market participants assess that this development could impact drug pricing strategies and the competitive landscape. However, as no official announcement has been made yet, definitive results are awaited. This is not investment advice.

📊 AZN — Piyasa Yorumu

▲ up · 65%

The news indicates that AstraZeneca (AZN) is approaching a reimbursement agreement in the UK for its key drug, Enhertu. This could potentially increase sales revenue and positively impact the stock price. Technical indicators support this view: the RSI at 59 is in neutral territory but trending upward, the MACD is above the signal line and positive, and the price is above both the 20-day and 50-day moving averages. The 4.86% rise in the last 24 hours suggests momentum may continue. However, I do not have high confidence due to the risk that the deal may not be finalized and the market may have already partially priced it in.

RSI 14

59.3

MACD

1.14

24h Δ

4.86%

📊 NICE — Piyasa Yorumu

▲ up · 60%

The news indicates that a price agreement with NICE is nearing, which could enhance access to Enhertu in the UK. The stock has risen 3.87% in the last 24 hours, with an RSI of 62.6 in neutral territory, showing no overbought signals. Although the MACD line remains below the signal line, it is in positive territory and trading above the SMA20 and SMA50. In the short term, positive news flow and a strong technical structure may support upward movement. However, due to the lack of finalization of the price agreement and the potential for MACD weakening, I do not have high confidence.

RSI 14

62.6

MACD

1.40

24h Δ

3.87%

Canlı Grafikler